Stock Events

Stock Events

SCRYPT INC 

$0.000200
3
+$0.00+0% Friday 00:00

Statistics

Day High
0.0002
Day Low
0.0002
52W High
0.0002
52W Low
0.0002
Volume
29
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Feb 23
$0.02
Dec 20
$0.02
Oct 17
$0.21
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30SepExpected
Q4 2015
Q1 2016
Q2 2016
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-0.05
0.1
0.25
0.4
Expected EPS
N/A
Actual EPS
-0.029

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics focuses on gene editing technologies, directly competing with Scrypt's gene therapy innovations.
Editas Medicine
EDIT
Mkt Cap433.1M
Editas Medicine specializes in genome editing technology, similar to Scrypt's focus on gene manipulation and therapy.
Intellia Therapeutics
NTLA
Mkt Cap1.67B
Intellia Therapeutics is a key player in CRISPR/Cas9 technology, a direct competitor in the gene editing space where Scrypt operates.
Beam Therapeutics
BEAM
Mkt Cap2.76B
Beam Therapeutics uses base editing technology, a form of gene editing that competes with Scrypt's gene therapy techniques.
Alnylam Pharmaceuticals
ALNY
Mkt Cap30.6B
Alnylam Pharmaceuticals is involved in RNAi therapeutics, which can be seen as a competing approach to Scrypt's gene-based therapies.
Ionis Pharmaceuticals
IONS
Mkt Cap9.51B
Ionis Pharmaceuticals develops RNA-targeted therapies, which are alternative approaches to Scrypt's gene therapy methods.
Biomarin Pharmaceutical
BMRN
Mkt Cap13.04B
BioMarin Pharmaceutical offers gene therapy products, competing in the same market as Scrypt for genetic disease treatments.
Vertex Pharmaceuticals
VRTX
Mkt Cap128.19B
Vertex Pharmaceuticals incorporates CRISPR gene editing in some of its therapy development, competing in the gene therapy field with Scrypt.

About

Scrypt, Inc. develops and provides document management and delivery solutions for regulated industries. It offers Sfax that enables users to cloud fax without printing a physical document; Stak, a healthcare document platform that transforms the workflow through a cloud-based environment; and DocbookMD, a messaging application for physicians. The company also provides XDOC, an electronic document management system that simplifies the mortgage lending process; and FaxAgent, a fax solution. It serves healthcare and lending clients, as well as service providers. The company was formerly known as SecureCare Technologies, Inc. and changed its name to Scrypt, Inc. in March 2014. Scrypt, Inc. is based in Austin, Texas.
Show more...
CEO
Dr. Richard F. Corlin M.D.
Employees
6
Country
United States

Listings

0 Comments

Share your thoughts

FAQ

What is SCRYPT INC stock price today?▼
The current price of SYPT is $0.00 USD — it has increased by +0% in the past 24 hours. Watch SCRYPT INC stock price performance more closely on the chart.
What is SCRYPT INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange SCRYPT INC stocks are traded under the ticker SYPT.
What were SCRYPT INC earnings last quarter?▼
SYPT earnings for the last quarter are -0.03 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
Does SCRYPT INC pay dividends?▼
Yes, SYPT dividends are paid en. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does SCRYPT INC have?▼
As of August 22, 2026, the company has 6 employees.
In which sector is SCRYPT INC located?▼
SCRYPT INC operates in the Technology sector.
When did SCRYPT INC complete a stock split?▼
The last stock split for SCRYPT INC was on May 21, 2007 with a ratio of 1:200.
Where is SCRYPT INC headquartered?▼
SCRYPT INC is headquartered in Austin, United States.